The largest community for pharma industry

TPMG FEATURED WRITER NEWSLETTER

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare Scenario

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Field Medical Affairs In Pharma/Biotech: Effectiveness, Opportunities and Challenges

  Medical Affairs has risen very fast in the last years, becoming after an initial phase of “supporting function”, a...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the...

Medical Insights in Pharma Industry by Tommaso Salanitri

Gain an insight means obtain an accurate and deep understanding about some (complex) situation. Medical insights represent one of the most...

Patient Experience is not Customer Experience and Pharma needs to get this.

The search volume of the term "Patient Experience" increased almost 550% in the past decade. Consultants, agencies, start ups...

Business Analysis in Pharma Industry: from Market Research to Patient Journey. A Medical Affairs view

by Tommaso Salanitri, MD Business analysis in Pharma industry, either during the early phases of drug development phase or close...

Preparing for take-off: a ticket to first class MCM planning

by Jan Keuppens “Omnichannel strategist / head of Marketing” @ Across health You wouldn’t attempt to fly a plane without first...

Targeting the Tumor Microenvironment

Investigators are always looking for new and innovative ways to treat cancer. This is a constantly and rapidly evolving...

Why Pharma Needs to Care About Global Warming

A version of this article was previously published on Pharmaphorum. Barely a day goes by without global warming or climate...

EDITOR´S PICK

Merck Announces Appointment of Organon & Co. General Counsel

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of...

Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that on July 28, 2020, at 12:00 p.m. EDT it...

Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of...

European Commission Grants Conditional Marketing Authorization for Gilead’s Veklury® (remdesivir) for the Treatment of COVID-19

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted conditional marketing authorization...

Bayer announces agreements to resolve major legacy Monsanto litigation

LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer announced today a series of agreements that will substantially resolve major outstanding Monsanto litigation, including U.S....

Sony’s mSafety™ Study Finds Nearly 90 Percent of People Surveyed with Chronic Conditions Believe a Remote Health Monitoring Device Could Help Them Better Manage...

SAN MATEO, Calif.--(BUSINESS WIRE)--Sony’s mSafety Wearable Platform Division today announced findings from a study of more than 2,000 people...

U.S. court rules in favor of Mylan over Biogen’s key MS drug patent

(Reuters) - A U.S. district court on Thursday ruled in favor of generic drugmaker Mylan NV in a patent...

Pfizer’s hemophilia gene therapy shows sustained effect in early-stage study

The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2,...

Akili Announces FDA Clearance of EndeavorRxTM for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game

BOSTON--(BUSINESS WIRE)--Akili today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as...

U.S. appeals court rejects rule requiring drug prices in TV ads

(Reuters) - A U.S. appeals court on Tuesday upheld a ruling that struck down a Trump administration rule that...

U.S. FDA revokes emergency use status of drug touted by Trump for COVID-19

(Reuters) - The U.S. Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat...

German insurers propose multi-billion euro pandemic fund

FRANKFURT (Reuters) - German insurers are putting together plans for a multi-billion euro public-private fund to help companies deal...

Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to...

Regeneron begins human testing of COVID-19 antibody cocktail

(Reuters) - Regeneron Pharmaceuticals Inc on Thursday said it has begun human testing of its experimental antibody cocktail as...

Moderna to start final testing stage of coronavirus vaccine in July

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus...

LOOK WHO IS ON THE MOVE!

Merck Announces Appointment of Organon & Co. General Counsel

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of...

Terrace Global Announces Appointment of Former Charlotte’s Web President and CEO, Hess Moallem, to Its International Advisory Board

TORONTO--(BUSINESS WIRE)--Terrace Global Inc. (“Terrace Global” or the “Company”) (TSXV: TRCE) is pleased to announce that Hesaam “Hess” Moallem...

Leankor Announces Executive Team Expansion to Drive Global Sales and Customer Success Operations

CALGARY, Alberta--(BUSINESS WIRE)--Leankor, a SaaS enterprise work and project management solution developed to address large, long-running and complex projects...

Huami Appoints Brad Samson as Vice President Investor Relations

CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. and Huami-USA (NYSE: HMI), whose mission is to connect health with technology, today announced that...

Bob Goeltz to Join Arcus Biosciences as Chief Financial Officer

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that...

Eko Appoints New Commercial Leader

OAKLAND, Calif.--(BUSINESS WIRE)--Eko today announced the appointment of digital health sales veteran Bryan Humbarger to the position of Senior...

Knopp Biosciences Appoints Stephen E. Butts to Board of Managers

PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory...

Coeus Consulting Group Appoints Lee Termini to its Board of Directors

DEVON, Pa.--(BUSINESS WIRE)--Coeus Consulting Group, a leading boutique life sciences consulting firm, and wholly owned subsidiary of Coeus Holdings,...

Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer

SAN DIEGO, Calif.--(BUSINESS WIRE)--Kinnate Biopharma Inc., a precision oncology company focused on the discovery and development of novel kinase...

Cardurion Pharmaceuticals Announces Appointment of Chris Morabito, M.D., as Chief Medical Officer

BOSTON--(BUSINESS WIRE)--Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the...

Lava Therapeutics Appoints Oncology and Hematology Expert Benjamin Winograd, M.D., Ph.D., as Chief Medical Officer

UTRECHT, The Netherlands & PHILADELPHIA--(BUSINESS WIRE)--Lava Therapeutics B.V., a biotech company pioneering bispecific gamma-delta T cell engagers for cancer,...

Edgewise Therapeutics Appoints Abby H. Bronson, M.B.A., as Vice President, Patient Advocacy and External Innovation

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of...

IM Therapeutics Expands Management Team with Appointments of Tom Shea as CFO/COO and Dr. Sarah Bird as VP, Clinical Development

WOBURN, Mass.--(BUSINESS WIRE)--ImmunoMolecular Therapeutics, Inc. (“IM Therapeutics”), a leading innovator in the field of precision medicine for autoimmune disease,...

BWXT Appoints Martyn Coombs to Lead Nuclear Medicine Business as President, BWXT ITG Canada

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) today announced that Martyn Coombs has been appointed president, BWXT ITG Canada,...

Dr. Carl Craig Has Been Promoted to CEO for Both Agricor Laboratories and Botanacor Laboratories. Dr. Craig Had Been the Companies’ COO.

DENVER--(BUSINESS WIRE)--Agricor Laboratories and Botanacor Laboratories jointly announced that Carl Craig has assumed the role of CEO of both...

REGULATORY AFFAIRS

BRILINTA Granted FDA Priority Review for the Reduction of Subsequent Stroke in Patients Who Had an Acute Ischemic Stroke or Transient Ischemic Attack

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application...

LEO Pharma announces U.S. Food and Drug Administration (FDA) acceptance of Biologics License Application (BLA) for tralokinumab for the treatment of adults with moderate-to-severe...

BALLERUP, Denmark, & MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced that the Biologics...

LYNPARZA® (olaparib) Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer

KENILWORTH, N.J.--(BUSINESS WIRE)--AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that...

Croma-Pharma announces submission for their botulinum toxin to treat glabellar (frown) lines to the German authority BfArM

LEOBENDORF, Austria--(BUSINESS WIRE)--On July the 8th, Croma-Pharma GmbH (Croma) has stated that the company submitted the drug file of...

FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product

NEW YORK--(BUSINESS WIRE)--Regulatory News: The U.S. Food and Drug Administration (FDA) today authorized the marketing of IQOS, Philip Morris International’s...

Astex Pharmaceuticals, Taiho Oncology, and Otsuka Pharmaceutical Announce FDA and Health Canada Approval of INQOVI® (Decitabine and Cedazuridine) Tablets, Oral Hypomethylating Agent (HMA) Therapy...

PLEASANTON, Calif. & PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc.; Taiho Oncology, Inc.; and Otsuka Pharmaceutical Co., Ltd. today...

FDA Approves Talaris Therapeutics’ IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients With a Severe Form of Scleroderma

BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the...

Merck and Eisai Receive Complete Response Letter for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma

KENILWORTH, N.J. & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and...

Concert Pharmaceuticals Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough...

Aldeyra Therapeutics Announces New Drug Application (NDA) Development Plans for Dry Eye Disease

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies...

 FDA Grants Orphan Drug Designation to Neurogene’s Gene Therapy for the Treatment of CLN5 Batten Disease

NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded with a mission to bring life-changing genetic medicines to patients and families...

Dascena Receives FDA Breakthrough Device Designation for Machine Learning Algorithm for Earlier Prediction of Acute Kidney Injury

OAKLAND, Calif.--(BUSINESS WIRE)--Dascena, Inc., a machine learning diagnostic algorithm company that is targeting early disease intervention to improve patient...

EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer

TOKYO & MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the European Medicines Agency (EMA) has...

ADC Therapeutics Announces U.S. Food and Drug Administration Has Lifted Partial Clinical Hold on Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine

LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE:ADCT), a clinical-stage oncology-focused biotechnology company leading the development and commercialization of next-generation antibody...

RESEARCH AND DEVELOPMENT

Kronos Bio Reports Positive Results of Preclinical Study of KB-0742, an Investigational CDK9 Inhibitor, Demonstrating Potency, Selectivity and Anti-tumor Activity in Prostate Cancer Model

SAN MATEO, Calif., & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kronos Bio, Inc., dedicated to targeting oncogenic transcription factors and their associated transcriptional...

Bayer’s Finerenone Meets Primary Endpoint in Phase III FIDELIO-DKD Renal Outcomes Study in Patients With Chronic Kidney Disease and Type 2 Diabetes

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the Phase III study FIDELIO-DKD, which is evaluating the efficacy and safety of finerenone...

Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral...

Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eikonizo Therapeutics, Inc., a biotechnology company developing novel, first-in-class brain-penetrant HDAC6 inhibitors to slow or stop progression...

ViiV Healthcare Announces Superior Efficacy of Investigational, Long-Acting Injectable Formulation of Cabotegravir Dosed Every Two Months Over Daily Oral PrEP

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as...

LivaNova Announces Publication Detailing the Design of the RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a publication in Contemporary Clinical Trials1,...

Horizon Discovery Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows

CAMBRIDGE, England--(BUSINESS WIRE)--Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the...

Merck Announces New Analyses Showing Additional Safety and Efficacy Data for Investigational Islatravir in Combination with Doravirine in Adults with HIV-1 Infection

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new analyses from...

GenSight Biologics Reports Sustained Efficacy and Safety Among LHON Patients Three Years After LUMEVOQ® Treatment

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and...

BELLUS Health Announces Topline Results from its Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing...

AVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical Trials

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from...

Sunovion Announces Topline Results from Global Phase 2 Study of SEP-4199 in Patients with Bipolar I Depression

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced topline results from study SEP380-201, a global, multicenter, randomized, double-blind, placebo-controlled...

Gilead Sciences Presents Data Supporting a Potential Six-Month Dosing Interval for Investigational HIV-1 Capsid Inhibitor Lenacapavir (GS-6207)

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from an ongoing Phase 1 study, which showed...

Deciphera Announces Presentation of Analysis of Crossover Population from the INVICTUS Phase 3 Study of QINLOCK™ (ripretinib) in Patients with Fourth-Line Advanced GIST

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced the presentation of new data from an exploratory analysis of progression-free...

Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-Small Cell Lung Cancer and Metastatic Castration-Resistant Prostate Cancer

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), today announced it will join the Exelixis and Roche clinical collaboration and...

FINANCIAL NEWS

Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Third Quarter Results

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on...

Seattle Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2020 Financial Results on July 30, 2020

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its second quarter 2020 financial results...

Inogen to Announce Second Quarter 2020 Financial Results on Tuesday, August 4th, 2020

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare...

Acceleron Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta...

VarmX Raises €32 Million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on...

LEIDEN, The Netherlands--(BUSINESS WIRE)--VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation,...

McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2021 financial results before market open on Monday,...

LabCorp to Announce Second Quarter Financial Results on July 28, 2020

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on...

AtriCure to Announce Second Quarter 2020 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage...

Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), announced today that the underwriters of its recently closed underwritten public offering...

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2020 Earnings Release

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third...

Citryll completes € 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps

OSS, Netherlands--(BUSINESS WIRE)--Citryll announced it closed a total fundraise of € 18.5 million, led by Seventure (including their Health...

Simulations Plus Sets Date for 3rd Quarter 2020 Earnings Release and Conference Call

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form...

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2020 on Wednesday, July 29, 2020

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the...

Pfizer Declares Third-Quarter 2020 Dividend

NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc. (NYSE:PFE) today declared a 38-cent third-quarter 2020 dividend on the...

BioGeneration Ventures Closes BGV IV Fund at €105 Million

NAARDEN, The Netherlands--(BUSINESS WIRE)--BioGeneration Ventures (BGV), a leading early-stage VC in European biopharma, announces the closing of its fourth...

INDUSTRY NEWS

Bien-Etre Labs Achieves Seven Million Dollars ($7M) Investment Funding

HIGH POINT, N.C.--(BUSINESS WIRE)--Bien-Etre Labs, (www.bienetre.com) a nutraceutical research, discovery and development company focusing on pre- and probiotic products...

ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics

TORONTO--(BUSINESS WIRE)--ProteinQure, a leader in computational protein drug discovery, announces a collaboration with the global biopharmaceutical company AstraZeneca to...

LGC Acquires The Native Antigen Company, Strengthening its Offer to the IVD Sector

LONDON & OXFORD, England--(BUSINESS WIRE)--Today, LGC announced the acquisition of The Native Antigen Company (NAC), one of the world’s...

Stoke Therapeutics Announces Publication of Data in the Journal Nature Communications That Support the Company’s Proprietary Approach to Addressing Severe Genetic Diseases by Precisely...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause...

Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases

SAN MATEO, Calif.--(BUSINESS WIRE)--Tranquis Therapeutics, a private immuno-neurology company, launched today with $30 million in Series A funding committed...

Walgreens Boots Alliance Reports Fiscal 2020 Third Quarter Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2020,...

Zymeworks Announces New Multispecific Antibody Collaboration with Merck

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that it and...

Saladax Biomedical launches clozapine test in the US after FDA grants market authorization

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical Inc., announced that the FDA has granted their De Novo Request for a rapid blood...

Renovion Announces Publication of Research Demonstrating the Impact of the Novel Treatment, Arina-1 on Mucus Transport in Cystic Fibrosis

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic...

JS InnoPharm Announces First Patient Dosed with JSI-1187, a Selective ERK Inhibitor, in Phase 1 Clinical Study for Advanced Solid Tumors with MAPK Pathway...

CHICAGO & SHANGHAI--(BUSINESS WIRE)--JS InnoPharm Ltd today announced the enrollment of the first patient in a Phase 1, open-label,...

  Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today it has pledged $100 million to the new Antimicrobial Resistance (AMR)...

Perceived burden of disease is greater in younger people living with COPD, global survey reveals

INGELHEIM, Germany--(BUSINESS WIRE)--Results of a global survey of 1,375 adults aged at least 45 years old and living with...

VALBIOTIS: Authorization to Launch the International Phase II/III REVERSE-IT Clinical Study on TOTUM-63, to Reduce Type 2 Diabetes Risk Factors

LA ROCHELLE, France--(BUSINESS WIRE)--Regulatory News: VALBIOTIS (FR0013254851 - ALVAL / PEA/SME eligible), a Research & Development company committed to scientific...

Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of...

Xencor and Atreca Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies

MONROVIA, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies...

EVENTS NEWS

Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that on July 28, 2020, at 12:00 p.m. EDT it...

New Findings on Gilead’s Biktarvy® Presented at AIDS 2020: Virtual Include Positive Switch Data in Older Adults

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced data demonstrating the safety and efficacy of the once-daily,...

Physicians’ Education Resource® Adds Heather A. Wakelee, M.D., as a Program Co-Chair of the 21st Annual International Lung Cancer Congress®

CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource®, LLC (PER®), is pleased to announce that Heather A. Wakelee, M.D., professor of oncology...

Merck Underscores Commitment to HIV with New Data Analyses to be Presented at AIDS 2020: Virtual

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today upcoming presentations of...

Lineage Cell Therapeutics to Present OpRegen® Data at International Society for Stem Cell Research (ISSCR) 2020 Virtual Annual Meeting

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies...

RubrYc Therapeutics To Present at AACR Virtual Conference

SAN CARLOS, Calif.--(BUSINESS WIRE)--RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies to improve outcomes for cancer...

HiFiBiO Therapeutics Presents Three Novel Immuno-Oncology Programs at 2020 AACR Virtual Annual Meeting II

CAMBRIDGE, Mass. & PARIS & SHANGHAI & HONG KONG--(BUSINESS WIRE)--HiFiBiO Therapeutics is presenting its three lead pipeline programs at...

F-star Therapeutics Presents Data on FS222 at 2020 AACR Annual Meeting

CAMBRIDGE, UK and CAMBRIDGE, MA--(BUSINESS WIRE)--F-star Therapeutics Ltd., a clinical-stage biopharmaceutical company focused on transforming the lives of patients...

Ribon Therapeutics Presents Additional Preclinical Data on its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of its Platform at the AACR 2020...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ribon Therapeutics, a clinical stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced new...

Transgene Presents Promising New Data from its Next-Generation Immunotherapy Platforms at AACR 2020

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

Exicure Presents Cavrotolimod (AST-008) Clinical Data at AACR 2020 Virtual Meeting

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic...

Acceleron to Host Conference Call and Webcast to Review Results of PULSAR Phase 2 Trial of Sotatercept Presented at American Thoracic Society 2020 Virtual...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta...

VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified

CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI") a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines,...

50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--ImmunSYS, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products, reported...

EpimAb Biotherapeutics Presents Preclinical Data Characterizing EMB-01 at AACR Virtual Annual Meeting II

SHANGHAI--(BUSINESS WIRE)--EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today presented preclinical data at the 2020...

COVID-19

Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment

STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain...

ChromaDex Announces New Study Results Highlighting Promising Anti-Viral Effects of Niagen® in Coronavirus Cell Model

LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC) today announced the latest preclinical findings indicating Niagen® (patented nicotinamide riboside) inhibits replication of...

Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate

CAMBRIDGE, Mass. & MADRID--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and...

Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020

MIAMI--(BUSINESS WIRE)--Biorasi, a leading global full-service contract research organization (CRO), has announced the start of the company’s third COVID-19...

Ridgeback Biotherapeutics Announces Potential COVID-19 Treatment EIDD-2801 Will Leverage Innovative Testing Platform AGILE for Phase 2 Trial

MIAMI--(BUSINESS WIRE)--Ridgeback Biotherapeutics announces the start of enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801. The...

CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate

OSLO, Norway--(BUSINESS WIRE)--CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the expansion of its partnership with Sichuan Clover...

Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the U.S. During COVID-19 Shelter-in-Place Orders

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced data presented at the 23rd International AIDS Conference (AIDS...

Medidata Partners With CTI for Remote Source Review of Clinical Trials in Response to COVID-19

NEW YORK--(BUSINESS WIRE)--Medidata, the global leader in creating end-to-end solutions to support the entire clinical trial process, and a...

Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to...

ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of...

WESTPORT, Conn.--(BUSINESS WIRE)--ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc., (AMRI), a leading global contract research, development,...

Onsite COVID-19 Virus and Antibody Testing Now Available to Arizona Employers Testing 10 or More Employees

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--With COVID-19 cases spiking just as businesses are beginning to recover from shutdowns, many Arizona employers are...

ChromaDex and the NIH-NIAID Rocky Mountain Laboratories Announce Study to Assess the Therapeutic Potential of Niagen® in COVID-19 Animal Models

LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC) announced today the initiation of a preclinical study in collaboration with the National Institute...

Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) announced today study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative...

Ancestry® COVID-19 Study Points to Gene Associated with Male Susceptibility to COVID-19

LEHI, Utah & SAN FRANCISCO--(BUSINESS WIRE)--Ancestry®, the global leader in family history and consumer genomics, today announced a new,...

The Pershing Square Foundation Awards $3 Million to Innovative SARS-CoV-2 Research Projects

NEW YORK--(BUSINESS WIRE)--The Pershing Square Foundation (the “Foundation”) today announced that it has awarded $3 million to nineteen recipients...

NATALIE YEADON

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the...

Targeting the Tumor Microenvironment

Investigators are always looking for new and innovative ways to treat cancer. This is a constantly and rapidly evolving...

Why Pharma Needs to Care About Global Warming

A version of this article was previously published on Pharmaphorum. Barely a day goes by without global warming or climate...

Medical Marijuana and Cannabinoids for Cancer Therapy

Medical marijuana – or cannabis – is one of the hottest topics in oncology right now. This is especially...

Biologics and Biosimilars in Oncology

With many patents about to expire in coming years, the field of biologics in oncology is about to change...

Real-world Evidence (RWE) for Regulatory and Reimbursement Decisions

We have previously discussed the potential roles of real-world data (RWD) and real-world evidence (RWE) for drug access. However,...

Barriers to Personalized Medicine in Oncology

Did you know that the top 10 highest grossing drugs in the United States only help between 4-25% of...

Bionics and Exoskeleton Components for Patient Assistance

What is Bionics and Why Should You Care? Bionics – also known as biomechatronics – is the study of mechanical...

Artificial Intelligence in Pharma

Artificial intelligence, or AI for short, is one of the most highly anticipated digital healthcare technologies. While the concept of...

Future Thinking for Pharmaceutical Market Research

We have recently discussed several important considerations for pharma when looking into the future. While some future directions seem...